Latest Pre-clinical development Stories
WEST HAVEN, Conn., Jan. 23, 2015 /PRNewswire/ -- NanoViricides, Inc.
Early Phase Development Solutions Provides Dedicated Molecule Solution Teams including Scientific, Regulatory, and Project Management Experts to Accelerate Drug Development PRINCETON,
LAS VEGAS, Dec.
Enhanced features allow for improved data accuracy, advanced animal welfare, and labor reduction. ST. PAUL, Minn., Dec.
BIRMINGHAM, Ala., Dec.
SAN DIEGO, Nov. 18, 2014 /PRNewswire/ -- Organovo Holdings, Inc.
Addition of Respected Clinical Trials Company Expands MPI Research Capabilities to Include Human Phase I Testing MATTAWAN, Mich., Oct.
-- Enrollment in Huntington's Trial Suspended Pending Further Assessment of Preclinical Data -- SEATTLE, Oct.
GREENWICH, Conn., Aug.
However, Exit of Major Companies Will Lead to Competitive Volatility, According to Findings from Decision Resources Group BURLINGTON, Mass., July 30, 2014 /PRNewswire/ -- Decision Resources